Zeria Pharmaceutical
4559.T
#6188
Rank
C$0.99 B
Marketcap
$22.64
Share price
0.49%
Change (1 day)
19.72%
Change (1 year)

P/E ratio for Zeria Pharmaceutical (4559.T)

P/E ratio as of December 2024 (TTM): 11.7

According to Zeria Pharmaceutical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 11.7382. At the end of 2023 the company had a P/E ratio of 15.8.

P/E ratio history for Zeria Pharmaceutical from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202315.8-28.95%
202222.3-30.57%
202132.1-8.54%
202035.124.71%
201928.16.72%
201826.40.07%
201726.316.88%
201622.5-45.84%
201541.6129.69%
201418.119.72%
201315.1-28.9%
201221.3-4.49%
201122.3-44.88%
201040.48.05%
200937.437.58%
200827.224.82%
200721.8-41.34%
200637.2

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.